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Purpose: We performed this study to evaluate the safety of permissive hypoten-
sion management in extremely low birth weight infants (ELBWIs). Materials and 
Methods: Medical records of all inborn ELBWIs admitted to Samsung Medical 
Center from January 2004 to December 2008 were reviewed retrospectively. Of a 
total of 261 ELBWIs, 47 (18%) required treatment for hypotension (group T), 110 
(42%) remained normotensive (group N), and 104 (40%) experienced more than 
one episode of hypotension without treatment (group P) during the first 72 hours 
of life. Treatment of hypotension included inotropic support and/or fluid loading. 
Results: Birth weight and Apgar scores were significantly lower in the T group 
than the other two groups. In the N group, the rate of pathologically confirmed 
maternal chorioamnionitis was significantly higher than other two groups, and the 
rate was higher in the P group than the T group. After adjusting for covariate fac-
tors, no significant differences in mortality and major morbidities were found be-
tween the N and P groups. However, the mortality rate and the incidence of intra-
ventricular hemorrhage (≥stage 3) and bronchopulmonary dysplasia (≥moderate) 
were significantly higher in the T group than the other two groups. Long term neu-
rodevelopmental outcomes were not significantly different between the N and P 
groups. Conclusion: Close observation of hypotensive ELBWIs who showed 
good clinical perfusion signs without intervention allowed to avoid unnecessary 
medications and resulted in good neurological outcomes.
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INTRODUCTION
Early hypotension during the initial 3 days of life is common in preterm infants 
and the incidence of early hypotension has been reported to range between 20-
50% in very low birth weight infants.1-3 Many studies have reported that hypoten-
sion might be related to cerebral hemorrhage and ischemia, and have demonstrated 
that hypotension is associated strongly with intraventricular hemorrhage (IVH) 
and periventricular leukomalacia.4,5 Fanaroff, et al.6 showed that infants treated for 
hypotension have higher mortality and worse morbidities, including delayed motor 
development and hearing loss, than their non-hypotensive counterparts. However, So Yoon Ahn, et al.
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permissive hypotension group (P group; MAP <gestational 
age with signs of good perfusion and no intervention), and 
3) a treated hypotension group (T group; MAP <gestational 
age and intervention including volume pushes, vasopres-
sors or corticosteroids).
GA was defined as the time from the date of the last men-
strual period to birth. Hypotension was defined as a blood 
pressure in mm Hg less than gestational age in weeks. We 
collected blood pressure (BP) data during the first 72 hours 
after birth at intervals of 6 hours and included the lowest 
blood pressure records, regardless of the interval during 
which they were taken. Peripheral blood pressure was mea-
sured using an oscillometric technique (M1866A, Philips 
Medical Systems, Inc., WA, USA) and invasive blood pres-
sure was measured using a calibrated pressure transducer 
(42584, ICU Medical, Inc., UT, USA) connected to an um-
bilical arterial catheter, which was positioned between tho-
racic vertebrae 6 to 10 in the abdominal aorta. End organ per-
fusion status was assessed by skin color, capillary refill rate, 
urine output, blood lactate level, and acidosis. 
We analyzed the following potentially confounding vari-
ables: gestational age, birth weight, gender, 1- and 5-minute 
Apgar scores, antenatal steroid use, mode of delivery, preg-
nancy-induced hypertension, pathologically confirmed cho-
rioamnionitis, small for gestational age (SGA),11 and respi-
ratory distress syndrome (RDS). SGA was defined as a 
birth weight less than ten percentile. RDS was defined as 
respiratory difficutly requiring surfactant and mechanical 
ventilation with endotracheal intubation. In addition, we 
evaluated the following outcome measures: death before 
discharge, bronchopulmonary dysplasia (≥moderate, need 
for oxygen or positive pressure support at 36 weeks post-
menstrual age),12 IVH (≥grade 3),13 periventricular leukom-
alacia, necrotizing enterocolitis (≥Bell’s stage 2b),14 and ret-
inopathy of prematurity15 requiring laser treatment. 
Long-term, 2-year outcomes including hearing impairment 
and cerebral palsy were investigated. Cerebral palsy, as diag-
nosed by a pediatric rehabilitation specialist or a pediatric 
neurologist, was defined as a non-progressive neurological 
disorder characterized by an inability to control posture and 
movement and abnormal tone in the limbs.16 Hearing impair-
ment was defined as the need for a hearing aid as recom-
mended by an otolaryngologist. Finally, the Bayley Scales 
of Infant Development-II17 mental development index (MDI) 
and psychomotor development index (PDI) at a corrected 
age of 18 months were assessed.
The software package SPSS version 17 was used for all 
despite the significant consequences of hypotension, even 
the definition of hypotension in extremely low birth weight 
infants (ELBWIs) is controversial.1 In addition, the guide-
lines for the treatment of hypotension have not clearly been 
defined and are still somewhat arbitrary.7 In one study, hy-
potension was defined as a mean arterial pressure (MAP) 
<30 mm Hg,4 while hypotension in another study, was de-
fined as <10th percentile of MAP for birth weight and post-
natal age based on published normative data.8 In practice, 
an infant with a MAP less than his/her gestational age (GA) 
in weeks is generally accepted to have hypotension. Treat-
ment regimens for early hypotension for ELBWI infants de-
pend on the neonatal intensive care units (NICU) in which 
they are treated.4 Intervention rates vary from 29-98% and 
include volume expansion, inotropic support and cortico-
steroids.9 Al-Aweel, et al.10 reported that some units used 
vasopressors 5- to 30-fold more frequently than other units. 
Dempsey, et al.7 advocated the concept of permissive hypo-
tension to treat hypotension in ELBWIs. Preterm infants 
with a mean arterial blood pressure lower than their number 
of gestational weeks often have no clinical signs of shock, 
presumably have adequate tissue oxygen delivery, and may 
therefore not need treatment. This approach to manage hypo-
tension in ELBWIs involves the overall assessment of per-
fusion signs (skin color, capillary refill rate, urine output, 
blood lactate level, and acidosis), not just an assessment of 
numerical blood pressure.9 However, only a handful of 
studies have investigated permissive hypotension manage-
ment of ELBWIs. We have used permissive hypotension to 
manage hypotensive ELBWIs in the Samsung Medical 
Center NICU for the past 7 years. Therefore, we designed 
the present study to investigate blood pressure trends dur-
ing the initial 72 hours from birth and to compare the mor-
tality and morbidities among ELBWIs within permissive 
hypotension, treated hypotension or normotension.
MATERIALS AND METHODS
　　　
We retrospectively reviewed the medical records of ELBWIs, 
weighing less than 1000 g, who were born at Samsung Medi-
cal Center between January 2004 and December 2008 and 
admitted to the neonatal intensive care unit. Patients were 
excluded if they had lethal congenital malformations. We 
grouped infants according to their lowest MAP level and 
management during the first 72 hours of life into 1) a nor-
motension group (N group; MAP >gestational age), 2) a Permissive Hypotension in ELBWIs
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were significantly lower in the T group than the other two 
groups. The incidence of pathologically confirmed chorio-
amnionitis was significantly higher in the N group than the P 
and T groups, and higher in the P group than the T group. 
Mean blood pressure trends
Invasive blood pressure monitoring was performed in 56% 
(62/110) infants in the N group, 54% (56/104) infants in the 
P group, and 77% (36/47) infants in the T group. The T 
group depicted significantly higher rate of invasive BP mon-
itoring (p-value: 0.02). The trend in mean blood pressures 
for all ELBWIs is shown in Fig. 1, while the trends in mean 
blood pressures of the N/P/T groups during the initial 72 
hours of life are shown in Fig. 2. A spontaneous increase in 
mean arterial blood pressure was observed in the N and P 
groups, with a statistically significant difference in MAP be-
tween the N and P groups at every time point. In the T group, 
hypotension developed usually and was treated within 12 
hrs from birth. Although the T group received treatment, in-
statistical analyses. ANOVA was used for continuous vari-
ables with normal distributions. To compare nominal vari-
ables such as mortality and morbidity, chi-square tests with 
binary logistic regression analysis were performed. Data 
are expressed as mean+SEM; and p-values less than 0.05 
were considered significant.
 
RESULTS
 
Demographic data
During the 4-year study period, 261 infants were born and 
admitted to the Samsung Medical Center NICU. Seven died 
within 72 hours of birth and had incomplete blood pressure 
data. We evaluated a total of 261 ELBWIs: 110 (42%) in the 
N group, 104 (40%) in the P group, and 47 (18%) in the T 
group. Table 1 lists the subjects’ demographic characteristics. 
Birth weight was significantly lower in the T group than the 
other two groups. The 1-minute and 5-minute Apgar scores 
Table 1. Subject Demographics
N group (n=110) P group (n=104) T group (n=47)
Gestational age (wks) 26
+5±2
+2 25
+6±2
+1 25±2
+2
Birth weight (gm)   781±138    764±147   672±152*†
Gender (male) 55 (50%) 61 (59%) 25 (53%)
One-minute Apgar score       4.7±1.6   4.5±1.5    3.3±1.3*†
Five-minute Apgar score    7.3±1.3   7.0±1.0  6.1±1.8*†
Cesarean delivery 77 (70%) 82 (79%) 37 (79%)
Small for gestational age 14 (13%) 24 (23%) 12 (26%)
Antenatal steroids 22 (20%) 23 (22%) 13 (28%)
Pathologically confirmed chorioamnionitis 56 (51%)   40 (39%)*   10 (22%)*
Pregnancy-induced hypertension 20 (18%) 21 (20%)   5 (11%) 
*p<0.05 versus N.
†p<0.05 versus P.
Fig. 1. Mean blood pressures of all infants (A) and infants in each of the three groups (B) during the first 72 hours of life. Data are expressed as mean±SD (A), 
mean±SEM (B). *p<0.05 versus N, 
†p<0.05 versus P. SD, standard deviation; SEM, standard error of the mean.
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compared to the other two groups, and higher in the P group 
than the N group. In multivariate analyses, adjusted for 
confounding factors including birth weight, Apgar scores 
and pathologically confirmed chorioamnionitis, there was 
no significant difference in IVH rate between the N and P 
groups, but the rate of IVH in the T group was significantly 
higher than the other two groups. 
Severe IVH infants in the P group 
Even though the severe IVH rate in the P group was not sig-
nificant after multivariate analysis, severe IVH was seen in 
more infants in the P group than in the N group. The gesta-
tional ages of 90% (18/20) of infants with severe IVH 
ranged from 23 to 26 weeks. To compare trends in the blood 
pressures of infants with and without severe IVH, the P 
group was divided into two subgroups: an IVH group and a 
non-IVH group. The data were analyzed according to gesta-
fants in this group had a consistently lower mean blood 
pressure than infants in the N and P groups after 12 hours 
from birth. Infants with hypotension received treatment be-
cause of pneumothorax, severe pulmonary hypertension, or 
their cardiopulmonary resuscitation status. In T group in-
fants, 87% (41/47) received volume expansion treatment 
(10 mL/kg of normal saline or bivon), 60% (28/47) dopa-
mine, 30% (14/47) dobutamine, and 25% (12/4) intermit-
tent epinephrine injections.
Adverse outcomes
The mortality rate and the incidence of moderate to severe 
bronchopulmonary dysplasia (BPD) were significantly 
higher in the T group than the other two groups even after 
adjusting for birth weight, Apgar score, and pathologically 
confirmed chorioamnionitis (Table 2 and 3). The incidence 
of severe IVH (≥grade 3) was the highest in the T group 
Fig. 2. Blood pressure trends of ELBWIs in the P group with and without severe intraventricular hemorrhage (≥grade 3) at gestational weeks 23-26. IVH, in-
traventricular hemorrhage; ELBWIs, extremely low birth weight infants.
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dence of cerebral palsy, hearing loss, or developmental de-
lay, defined as Bayley score MDI or PDI <75 (Table 4). 
None of the infants developed blindness. Due to substantial 
proportion of missing data and follow-up loss, the long-
term neurological outcomes of group T were not analyzed.
DISCUSSION
In this retrospective study, we characterized blood pressure 
trends during the initial 72 hours from birth and compared 
the mortality and morbidities between normotensive and 
permissive hypotension infants. The mortality rate and inci-
dence of severe IVH and moderate to severe BPD were high-
tional week to account for the potentially confounding effect 
of number of gestational weeks. The IVH subgroup of in-
fants showed a blood pressure trend similar to that of the 
non-IVH subgroup for gestational weeks 23-26 within 72 
hours of birth (Fig. 2). 
Long-term outcomes
A total of 97/110 (88%), 87/104 (84%), and 23/47 (49%) 
ELBWIs from the N, P, and T groups, respectively, were 
discharged successfully. Of these, 89 (92%), 83 (95%), and 
20 (87%) were followed-up for 2 years, and Bayley testing 
was performed in 28 (29%), 33 (38%), and 8 (17%) pa-
tients from the N, P, and T groups, respectively. There was 
no significant differences between groups N and P in inci-
Table 2. Mortality and Major Morbidities of Extremely Low Birth Weight Infants
N group (n=110) P group (n=104) T group (n=47) p value
PDA 86/110 (78%) 89/103 (86%) 38/43 (88%) 0.13
BPD (≥moderate) 30/101 (30%)   33/90 (37%) 18/26 (69%)*†   0.001
NEC (≥stage 2)   7/109 (6%)   10/99 (10%)   6/34 (18%) 0.15
ROP requiring laser surgery 23/104 (22%)   26/97 (27%) 13/33 (39%) 0.15
IVH (≥stage 3)   9/110 (8%) 18/104 (17%)* 18/40 (45%)*†   0.001
PVL   8/106 (8%)     8/88 (9%)   2/34 (6%) 0.83
Mortality 13/110 (12%) 17/104 (16%) 24/47 (51%)*†   0.001
PDA, patent ductus arteriosus; BPD, bronchopulmonary dysplasia; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; IVH, intraventricular 
hemorrhage; PVL, periventricular leukomalacia.
*p<0.05 versus N.
†p<0.05 versus P. 
Table 3. Odds Ratios for Mortality and Major Morbidities after Adjusting Birth Weight, Apgar Scores and Pathologically Con- Odds Ratios for Mortality and Major Morbidities after Adjusting Birth Weight, Apgar Scores and Pathologically Con- dds Ratios for Mortality and Major Morbidities after Adjusting Birth Weight, Apgar Scores and Pathologically Con- Morbidities after Adjusting Birth Weight, Apgar Scores and Pathologically Con- justing Birth Weight, Apgar Scores and Pathologically Con- ing Birth Weight, Apgar Scores and Pathologically Con-
firmed Chorioamnionitis 
 
 
P to N   T to N
p value      Odds ratio (95% CI) p value Odds ratio  (95% CI)
PDA 0.30 1.5 (0.7-3.2) 0.72 1.2 (0.4-3.9)
BPD (≥moderate) 0.51 1.2 (0.7-2.3) 0.02   3.6 (1.3-10.3)
NEC (≥stage 2) 0.38 1.5 (0.6-4.4) 0.11   2.9 (0.8-10.8)
ROP requiring laser operation 0.79 1.1 (0.5-2.2) 0.79 1.1 (0.4-3.0)
IVH (≥stage 3) 0.07 2.4 (1.0-5.9) 0.01   7.4 (2.6-21.5)
PVL 0.73 1.2 (0.4-3.4) 0.66 0.7 (0.1-3.8)
Mortality 0.92 1.0 (0.5-2.4) 0.01 3.3 (1.3-8.5)
N, normotensive group; P, permissive hypotension group; T, treated hypotension group; PDA, patent ductus arteriosus; BPD, bronchopulmonary dysplasia; 
NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; IVH, intraventricular hemorrhage; PVL, periventricular leukomalacia.
*p<0.05 versus N. 
†p<0.05 versus P. 
Table 4. Long-Term Neurodevelopmental Outcomes 
N group P group p value 
Delayed mental function, Bayley score, MDI <75     3/30 (10%)  3/36 (8%)  0.82
Delayed motor function, Bayley score, PDI <75     4/30 (13%)    5/36 (14%)  0.61
Hearing abnormalities 1/102 (1%) 1/90 (1%) 0.49
Cerebral palsy   14/89 (16%) 15/83 (18%) 0.28
MDI, mental development index; PDI, psychomotor development index.So Yoon Ahn, et al.
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hypotension was symptomatic or not and whether these ad-
verse outcomes resulted from symptomatic hypotension it-
self or the side-effects of treatments such as fluid replace-
ment and vasopressor agents. 
Pellicer, et al.20 therefore performed a cohort case-control 
study to determine the impacts of hypotension treatment on 
morbidity and neurodevelopmental outcomes in low birth 
weight infants, however, found no differences in the rates 
of neurodevelopmental outcomes. These authors suggested 
that cautious use of cardiotonics in early systemic hypoten-
sion appears to be safe. However, Pellicer, et al. defined hy-
potension based on numerical blood pressure value alone 
without considering organ perfusion or overall clinical con-
dition, therefore, they might have included healthy infants 
with transient hypotension in their analyses who were treat-
ed for hypotension. 
At the Samsung Medical Center NICU, hypotension in 
infants is managed only when infants exhibit hemodynami-
cally unstable status including unstable vital signs, and im-
paired perfusion signs such as delayed capillary refill, lack 
of a pinkish skin color, or decreased urine output. Non-
symptomatic hypotension infants are treated by using a per-
missive hypotension approach. We found in the present 
study that treatment of hypotension in ELBWIs was related 
to IVH, BPD and mortality. However, the treated hypoten-
sion infants were relatively more immature, and thus more 
likely to require intervention for hypotension. Although 
birth weight, Apgar score and pathologically confirmed 
chorioamnionitis were adjusted in comparison of morbidi-
ties and mortality, it was difficult to ascertain that worse 
outcomes in the T group were not related with their higher 
vulnerability.
Nonetheless, infants in the P group in the present study 
could avoid unnecessary treatment for hypotension, and the 
P group showed as good outcomes as the N group.
Limitations of this study include the fact that it was a ret-
rospective study, and 18 (38%) of 47 treated hypotension 
patients did not survive more than 7 days because of severe 
illness. Furthermore, only 69 (26%) of 261 infants were 
evaluated using Bayley tests, therefore, larger data would 
be needed for more reliable and constant conclusion. 
In the present study, invasive BP monitoring rate was sig-
nificantly higher in the T group, and this result could be re-
lated to the fact that the T group consisted of smaller babies 
who need central lines including umbilical arterial line 
more than others. However, between the N and P groups, 
no significant difference was observed in the ratio of inva-
er in treated hypotension infants than in permissive hypo-
tension or normotensive infants. There were no differences 
in mortality or morbidities, including neurodevelopment 
outcomes, between normotensive and permissive hypoten-
sion infants. The results of this study support the proposal 
that a permissive hypotension approach does not result in 
poor outcomes. 
Dempsey, et al.7 reported that careful observation without 
intervention in ELBWIs with hypotension (defined as 
BP<GA) and good perfusion signs resulted in outcomes as 
good as those of normotensive infants. In this earlier report, 
the most important factor informing the decision whether 
or not to treat hypotension was clinical assessment of end 
organ perfusion. By careful observation of peripheral perfu-
sion, Dempsey, et al. were able to reduce the number of in-
fants who received intervention. Although they reported 
only short-term outcomes, we herein evaluated long-term 
outcomes, as assessed by the 18 month corrected age Bay-
ley DMI and DPI scores, cerebral palsy, and hearing abnor-
malities. Consistent with the previous short-term study, we 
found that the long-term outcomes of permissive hypoten-
sion infants were as good as those of normotensive infants. 
The brain of preterm infants is known to be quite vulner-
able to hypoperfusion of cerebral blood flow.3 Several stud-
ies reported that hypotension infants who received dopa-
mine showed increased cerebral blood flow with increased 
blood pressure.18,19 Dopamine is regarded as the first choice 
and the most commonly used inotropic agent in hypoten-
sion of premature infants. The hypotension in ELBWIs 
might be related with myocardial dysfunction induced by 
umbilical cord clamping, therefore, the removal of placenta 
increases systemic vascular resistance. In such cases, dobu-
tamine may be more helpful by decreasing afterload and 
improving cardiac contractility. However, vasopressor ad-
ministration may induce sudden increase of blood pressure 
which is uncontrollable and possibly related with IVH or 
periventricular white matter injury.20 Fanaroff, et al.6 sug-
gested that hearing and delayed motor development are re-
lated to treatment of symptomatic hypotension,21 and an-
other study suggested that anti-hypotensive treatment is 
related to IVH, periventricular leukomalacia and major de-
velopmental impairments. Dopamine possibly induces 
worse outcomes than hypotension itself by rapidly chang-
ing cerebral hemodynamics.1,22 
In these earlier studies, however, no clear therapeutic cri-
teria or treatment protocols for hypotension treatment were 
used, thus making it hard to determine whether the treated Permissive Hypotension in ELBWIs
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9. Laughon M, Bose C, Allred E, O’Shea TM, Van Marter LJ, Bed-
narek F, et al. Factors associated with treatment for hypotension in 
extremely low gestational age newborns during the first postnatal 
week. Pediatrics 2007;119:273-80.
10. Al-Aweel I, Pursley DM, Rubin LP, Shah B, Weisberger S, Rich-
ardson DK. Variations in prevalence of hypotension, hypertension, 
and vasopressor use in NICUs. J Perinatol 2001;21:272-8.
11. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in 
length and head circumference as estimated from live births at 
gestational ages from 26 to 42 weeks. Pediatrics 1966;37:403-8.
12. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fan-
aroff AA, et al. Validation of the National Institutes of Health con-
sensus definition of bronchopulmonary dysplasia. Pediatrics 
2005;116:1353-60.
13. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolu-
tion of subependymal and intraventricular hemorrhage: a study of 
infants with birth weights less than 1,500 gm. J Pediatr 1978;92: 
529-34.
14. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton 
L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions 
based upon clinical staging. Ann Surg 1978;187:1-7.
15. An international classification of retinopathy of prematurity. The 
Committee for the Classification of Retinopathy of Prematurity. 
Arch Ophthalmol 1984;102:1130-4.
16. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, 
Vohr B, et al. Neurodevelopmental and growth impairment among 
extremely low-birth-weight infants with neonatal infection. JAMA 
2004;292:2357-65.
17. Leonard CH, Piecuch RE, Cooper BA. Use of the Bayley Infant 
Neurodevelopmental Screener with low birth weight infants. J Pe-
diatr Psychol 2001;26:33-40.
18. Pellicer A, Valverde E, Elorza MD, Madero R, Gayá F, Quero J, et 
al. Cardiovascular support for low birth weight infants and cere-
bral hemodynamics: a randomized, blinded, clinical trial. Pediat-
rics 2005;115:1501-12.
19. Munro MJ, Walker AM, Barfield CP. Hypotensive extremely low 
birth weight infants have reduced cerebral blood flow. Pediatrics 
2004;114:1591-6.
20. Pellicer A, Bravo MC, Madero R, Salas S, Quero J, Cabañas F. 
Early systemic hypotension and vasopressor support in low birth 
weight infants: impact on neurodevelopment. Pediatrics 2009;123: 
1369-76.
21. Fanaroff AA, Fanaroff JM. Short- and long-term consequences of 
hypotension in ELBW infants. Semin Perinatol 2006;30:151-5.
22. Synnes AR, Chien LY, Peliowski A, Baboolal R, Lee SK; Canadi-
an NICU Network. Variations in intraventricular hemorrhage inci-
dence rates among Canadian neonatal intensive care units. J Pedi-
atr 2001;138:525-31.
sive to non-invasive BP measuring method, indicating that 
this factor hardly affects the BP level and outcomes, at least 
between N group and P group.
In summary, a numerical blood pressure value lower than 
gestational age should not be used as the only indicator for 
treating early period hypotension in ELBWIs. Unnecessary 
treatment can be avoided by careful monitoring of ELBWIs 
with hypotension but good perfusion signs, and these in-
fants have outcomes as good as those of normotensive in-
fants. In contrast, hypotensive infants who showed unstable 
vital signs and received supportive treatment had higher 
mortality rate, and greater incidence of severe IVH (≥stage 
3) and BPD (≥moderate) than normotensive and permissive 
hypotension infants.
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